biotech · Glaucoma · Hepatocellular Carcinoma · AEON
AEON Biopharma
AEON Biopharma is a biotech organization headquartered in irvine, USA. It trades on NYSE under ticker AEON. Primary therapeutic focus areas include Glaucoma, Hepatocellular Carcinoma, Cervical Dystonia, Migraine, Congeni
irvine, USA HQ
11 Employees
Public company Type
AEON · NYSE Ticker
Company details
- Status
- Public
- HQ
- irvine, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 8
- Patents
- 9
ET1402L1-ARTEMIS™ T cells -IV
Phase 1 · mab · Hepatocellular Carcinoma
ET1402L1-ARTEMIS™ T cells -IV for Hepatocellular Carcinoma is a Phase 1 program (mab) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Internal code XJTU1AF2017LSL-C002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AEON Biopharma
- Phase
- Phase 1
- Modality
- mab
- Indication
- Hepatocellular Carcinoma
- Status
- completed
- Trials
- 1